microRNA‑18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes

Mao,Gang; Liu,Lei

doi:10.3892/etm.2014.1996

microRNA‑18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes

Authors:
- Gang Mao
- Lei Liu
View Affiliations

Affiliations: Intensive Care Unit, The Fourth People's Hospital of Jinan, Jinan, Shandong 250031, P.R. China, Department of Gastroenterology, The Fourth People's Hospital of Jinan, Jinan, Shandong 250031, P.R. China
Published online on: September 30, 2014 https://doi.org/10.3892/etm.2014.1996
Pages: 1901-1905

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the value of microRNA (miRNA)‑18a for the early diagnosis of cerebral injury in patients with type 2 diabetes. Blood samples were collected from patients with type 2 diabetes, admitted to hospital between January and December 2013. The patients were randomly divided into three groups, which included one control and two experimental groups of severely and mildly diabetic patients (33 individuals per group). The levels of biochemical indicators in the serum, including S100 protein, neuron‑specific enolase, myelin basic protein and endothelin-1, were determined. The mRNA and protein expression levels of hypoxia‑inducible factor (HIF)‑1α in the serum were measured by quantitative polymerase chain reaction (qPCR) and western blot analysis, respectively. In addition, the serum expression levels of miRNA‑18a were determined by qPCR. The concentrations of the biochemical indicators in the severe diabetes group were significantly higher compared with those from the other two groups. Furthermore, the mRNA and protein expression levels of HIF‑1α in the severe diabetes group were significantly upregulated compared with the other groups. However, the levels of miRNA‑18a in the severe diabetes group were significantly downregulated compared with the other groups. The present study demonstrated that the elevation of biochemical indicators in the serum and the upregulation of HIF‑1α mRNA and protein expression are associated with the downregulation of miRNA‑18a. Therefore, miRNA‑18a may be a potential genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes.

View Figures

View References

1	Minagawa S, Hanyu O and Sone H: Stroke in the elderly people with diabetes mellitus. Nihon Rinsho. 71:1948–1953. 2013.(In Japanese).
2	Palazzo P, Maggio P, Altavilla R, et al: Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease. PLoS One. 8:e832872013. View Article : Google Scholar : PubMed/NCBI
3	Mao X, Wang T, Liu Y, et al: N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats. PLoS One. 8:e689492013.PubMed/NCBI
4	Ayala de la Peña F, Kanasaki K, Kanasaki M, et al: Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma. J Biol Chem. 286:20778–20787. 2011.PubMed/NCBI
5	Luo F and Hu TH: Overexpression of miR-18a suppresses tumor angiogenesis in colon cancer. Zhonghua Xian Dai Yi Xue Za Zhi. 23:37–41. 2013.(In Chinese).
6	No authors listed. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 20:1183–1197. 1997. View Article : Google Scholar : PubMed/NCBI
7	Chromy BA, Eldridge A, Forsberg JA, et al: Wound outcome in combat injuries is associated with a unique set of protein biomarkers. J Transl Med. 11:2812013. View Article : Google Scholar : PubMed/NCBI
8	Siddiqi SS, Gupta R, Aslam M, Hasan SA and Khan SA: Type-2 diabetes mellitus and auditory brainstem response. Indian J Endocrinol Metab. 17:1073–1077. 2013. View Article : Google Scholar : PubMed/NCBI
9	Foerch C, Singer OC, Neumann-Haefelin T, et al: Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol. 62:1130–1134. 2005.PubMed/NCBI
10	Wang SZ, Ma CC, Cao LL, Wei RY and Chi ZF: Detection and significance of serum neuron-specific enolase in elderly stroke patients. Zhongguo Lao Nian Xue Za Zhi. 26:410–411. 2006.(In Chinese).
11	Wunderlich MT, Wallesch CW and Goertler M: Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci. 227:49–53. 2004. View Article : Google Scholar : PubMed/NCBI
12	Yanagisawa M, Kurihara H, Kimura S, Goto K and Masaki T: A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca²⁺ channels. J Hypertens Suppl. 6:S188–S191. 1988. View Article : Google Scholar : PubMed/NCBI
13	Morfoisse F, Kuchnio A, Frainay C, et al: Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1α-independent translation-mediated mechanism. Cell Rep. 6:155–167. 2014.PubMed/NCBI
14	Grebhardt S, Veltkamp C, Ströbel P and Mayer D: Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer. Int J Cancer. 131:2785–2794. 2012. View Article : Google Scholar : PubMed/NCBI
15	Liang J, Qian Y, Xu D, et al: Serum tumor markers, hypoxia-inducible factor-1α HIF-1α and vascular endothelial growth factor, in patients with non-small cell lung cancer before and after intervention. Asian Pac J Cancer Prev. 14:3851–3854. 2013.
16	Revet I, Feeney L, Tang AA, et al: Dysmyelination not demyelination causes neurological symptoms in preweaned mice in a murine model of Cockayne syndrome. Proc Natl Acad Sci USA. 109:4627–4632. 2012. View Article : Google Scholar : PubMed/NCBI
17	Sagar SK, Zhang C, Guo Q, et al: Role of expression of endothelin-1 and angiotensin-II and hypoxia-inducible factor-1α in the kidney tissues of patients with diabetic nephropathy. Saudi J Kidney Dis Transpl. 24:959–964. 2013.
18	Bertozzi D, Marinello J, Manzo SG, et al: The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1α activity by changing miR expression patterns in human cancer cells. Mol Cancer Ther. 13:239–248. 2014.PubMed/NCBI
19	Chai ZT, Kong J, Zhu XD, et al: MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma. PLoS One. 8:e779572013.PubMed/NCBI
20	Lemaire J, Mkannez G, Guerfali FZ, et al: MicroRNA expression profile in human macrophages in response to Leishmania major infection. PLoS Negl Trop Dis. 7:e24782013. View Article : Google Scholar : PubMed/NCBI